Allurion Technologies Inc (ALUR) USD0.0001
Sell:$2.40Buy:$2.51
$0.02
(0.82%)
- This stock can be held in a
Stocks and Shares ISA$0.02
(0.82%)$0.02
(0.82%)Company Information
About this company
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers and Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale. The Allurion Balloon is swallowed as a capsule under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia. The Allurion Balloon is a procedure-less intragastric balloon that does not require any surgery, endoscopy, or anesthesia for placement. The balloon is swallowed in a capsule during a discrete outpatient office visit that takes approximately 15 minutes (though times may vary across different outpatient offices). The Allurion Virtual Care Suite is a cutting-edge digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program.
Key people
Key facts
- EPICALUR
- LocationUnited States
- SectorTechnology
- IndustrySoftware & Programming
- ISINUS02008G2012
- Market cap$18.12m
- Employees134
- Shares in issue7.46m
- ExchangeNew York Stock Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.